Browsing eNauka
Browsing by Author Peric, S
Showing results 1 to 9 of 9
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Assessing efficacy and safety of gefurulimab in generalised Myasthenia gravis: Baseline characteristics from PREVAIL | Sacca, F; Gwathmey, K; Masuda, M; Habib, AA; Peric, S; Rakhade, S; Scholz, J; Shang, S; Howard, F | Conference Paper | Mp. category will be shown later |
| 2025 | Autonomic nervous system impairment in patients with chronic demyelinating polyneuropathies | Todorovic, T; Bozovic, I; Bijelica, B; Palibrk, A; Peric, S; Basta, I | Conference Paper | Mp. category will be shown later |
| 2025 | Baseline characteristics of the first 200 study participants with multifocal motor neuropathy in the iMMersioN study | Claeys, K; Hewamadduma, C; Peric, S; Querol, L; Altamimi, S; Van, De Walle I; Persson, E; Van, Hoomissen I; Szmyd, G; Vujcic, M;
Cadour, S; Van, De Steen O; Arvin-Berod, C; Allen, J;
| Conference Paper | Mp. category will be shown later |
| 2010 | Levels of glomerular filtration rate in patients with stroke | Ninkovic, M; Peric, S; Nikolic, Olivera R | Conference Paper | Mp. category will be shown later |
| 2026 | Patient-reported outcomes and safety from the phase 2 ARDA study of Empasiprubart in multifocal motor neuropathy | Pasnoor, M; Beadon, K; Gable, K; Harbo, T; Hewamadduma, C; Karam, C; Cadour, S; Persson, E; Vujcic, M; Querol, L;
Allen, J; Peric, S;
| Conference Paper | Mp. category will be shown later |
| 2025 | Redefining triple a syndrome: a multinational study of the neuromuscular phenotype in the largest genetically confirmed cohort to date | Oeztuerk, M; Leonard-Louis, S; De, Benito D Natera; Nascimento, A; Ortez, C; Viric, V; Stevic, Z; Nelke, C; Schaenzer, A; Previtali, S;
Cehic, M; Dumic, Katja; Peric, S; Roos, A; Ruck, T;
| Conference Paper | Mp. category will be shown later |
| 2025 | Safety and efficacy data from the phase 2 ARDA study of empasiprubart in multifocal motor neuropathy | Querol, L; ...; Peric, S; ...; (broj, koautora 17) | Conference Paper | Mp. category will be shown later |
| 2026 | Safety and efficacy of claseprubart, an active C1s inhibitor, in patients with generalized myasthenia gravis | Peric, S; Narayanaswami, P; Smilowski, M; Slowik, A; Gokhale, S; Briggs, C; Siddiqui, U; Randhawa, S; Truman, M; Hickey, L;
Shelly, S; Vu, T; Vissing, J;
| Conference Paper | Mp. category will be shown later |
| 2026 | Universal neurological involvement in triple-A syndrome: Evidence from the largest genetically confirmed cohort | Oeztuerk, M; Peric, S; Cehic, M; ...; Kosac, A; Stevic, Z; ...; (broj, koautora 32) | Conference Paper | Mp. category will be shown later |